Bone extracellular matrix and associated adhesion proteins (BEM)

The bone extracellular matrix (BEM) is a specialized, mineralized environment that provides the structural framework for the skeleton and serves as a dynamic reservoir for signaling molecules. It is composed of an inorganic phase, primarily hydroxyapatite crystals, and an organic phase consisting of Type I collagen and various non-collagenous proteins such as osteopontin, bone sialoprotein, and osteocalcin (Alford et al., 2015, PMID: 25831204). These adhesion proteins are critical for mediating interactions between the matrix and bone cells—osteoblasts, osteoclasts, and osteocytes—via integrin signaling, which regulates the processes of bone formation and resorption (Ganss et al., 1999, PMID: 10634573). The BEM also sequesters growth factors like TGF-beta and bone morphogenetic proteins (BMPs), which are released during remodeling to influence cellular behavior. Pathological changes in the BEM are central to metabolic bone diseases such as osteoporosis and the progression of bone metastasis, where the matrix provides a supportive niche for tumor cells (Boonen et al., 2011, PMID: 21427490). Therapeutic agents like bisphosphonates target the BEM by binding to hydroxyapatite to inhibit osteoclast-mediated resorption, while other strategies focus on modulating matrix-associated proteins to restore bone density and prevent fractures (Russell, 2011, PMID: 21439367).

Other names

Bone matrixOsseous extracellular matrixBone ECMMineralized extracellular matrix

Binding to hydroxyapatite to inhibit osteoclast activity; modulation of bone remodeling signaling pathways; sequestration of minerals and growth factors.